R-isomers of Arg-Gly-Asp (RGD) mimics as potent αvβ3 inhibitors

[1]  J. Debus,et al.  Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy , 2005, Clinical Cancer Research.

[2]  P. Colson,et al.  Practical Enantioselective Synthesis of β-Substituted-β-amino Esters , 2005 .

[3]  D. Griggs,et al.  A small molecule antagonist of the αvβ3 integrin suppresses MDA-MB-435 skeletal metastasis , 2004, Clinical & Experimental Metastasis.

[4]  T. Lectka,et al.  A multistage, one-pot procedure mediated by a single catalyst: a new approach to the catalytic asymmetric synthesis of beta-amino acids. , 2003, The Journal of organic chemistry.

[5]  L. Ellis,et al.  αvβ3 Integrin Antagonist S247 Decreases Colon Cancer Metastasis and Angiogenesis and Improves Survival in Mice , 2003 .

[6]  S. Mousa,et al.  The αv integrin antagonists as novel anticancer agents: an update , 2002 .

[7]  Richard O Hynes,et al.  Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.

[8]  P. Coleman,et al.  Ligands to the integrin receptor αvβ3 , 2002 .

[9]  B. Neustadt,et al.  Inhibition of Angiogenesis and Tumor Growth by SCH221153, a Dual αvβ3 and αvβ5 Integrin Receptor Antagonist , 2001 .

[10]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[11]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[12]  J. Hutchinson,et al.  Ligands to the integrin receptor αvβ3 , 2000 .

[13]  K. Ward,et al.  Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. , 2000, Journal of medicinal chemistry.

[14]  R. Gould,et al.  Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. , 1999, Journal of medicinal chemistry.

[15]  William F. Westlin,et al.  A Peptidomimetic Antagonist of the Integrin αvβ3 Inhibits Leydig Cell Tumor Growth and the Development of Hypercalcemia of Malignancy , 1998 .

[16]  M A Horton,et al.  A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. , 1997, The Journal of clinical investigation.

[17]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[18]  K. Williams,et al.  Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists. , 1995, Journal of medicinal chemistry.

[19]  J. Rico.  Synthesis of novel β-amino acid precursors : β-amino-hydrocoumarins as unusual aspartic acid mimetics used in fibrinogen receptor antagonists , 1994 .

[20]  R. Gould,et al.  Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. , 1994, Journal of medicinal chemistry.

[21]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[22]  R J Lynch,et al.  Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors. , 1992, Journal of medicinal chemistry.

[23]  I. Charo,et al.  Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. , 1991, The Journal of biological chemistry.

[24]  M. Hayashi,et al.  Novel purification of vitronectin from human plasma by heparin affinity chromatography. , 1988, Cell structure and function.

[25]  J. Koziol,et al.  Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. , 1987, Blood.

[26]  D. Griggs,et al.  Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247 , 2004, Clinical & Experimental Metastasis.

[27]  S. Mousa.  MECHANISMS OF ANGIOGENESIS IN VASCULAR DISORDERS : POTENTIAL THERAPEUTIC TARGETS , 1998 .

[28]  E. Ruoslahti,et al.  [27] Arginine-glycine-aspartic acid adhesion receptors , 1987 .